Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Deferred Revenue (2016 - 2025)

Veracyte (VCYT) has disclosed Current Deferred Revenue for 12 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 30.66% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 30.66% year-over-year, with the annual reading at $1.2 million for FY2025, 30.66% down from the prior year.
  • Current Deferred Revenue hit $1.2 million in Q4 2025 for Veracyte, up from $417000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.9 million in Q1 2022 to a low of $417000.0 in Q3 2025.
  • Historically, Current Deferred Revenue has averaged $2.3 million across 5 years, with a median of $2.2 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: soared 1152.29% in 2021 and later crashed 79.49% in 2025.
  • Year by year, Current Deferred Revenue stood at $4.6 million in 2021, then crashed by 43.76% to $2.6 million in 2022, then decreased by 23.15% to $2.0 million in 2023, then dropped by 16.68% to $1.7 million in 2024, then plummeted by 30.66% to $1.2 million in 2025.
  • Business Quant data shows Current Deferred Revenue for VCYT at $1.2 million in Q4 2025, $417000.0 in Q3 2025, and $1.4 million in Q2 2025.